Atracurium

Name	Atracurium
CAS Type 1 Name	Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl))-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-
Equivalent Terms	33 A 74 \| A 74, 33 \| Atracurium Besilate \| Atracurium Besylate \| Atracurium Dibesylate \| Besilate, Atracurium \| BW33A \| BW 33A \| BW-33A \| Glaxo Wellcome Brand of Atracurium Besilate \| Pisa Brand of Atracurium Besilate \| Relatrac \| Tracrium \| Wellcome Brand of Atracurium Besilate
CAS Registry Number	64228-79-1
Definition	A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
Structure
Top Interacting Genes
MeSH^® ID	D001279
External Links	ChEBI 64228-79-1 ChemIDplus^® 64228-79-1 DrugBank DB00732 Household Products Database 64228-79-1 PubChem D001279 TOXLINE^® Query

Top ↑ Ancestors

Chemicals ← Heterocyclic Compounds

← Heterocyclic Compounds, 2-Ring

← Isoquinolines

← Benzylisoquinolines

← Atracurium

Top ↑ Descendants

Atracurium
	cisatracurium